Related Articles
Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma
Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma
Abnormal alterations of miR‑1 and miR‑214 are associated with clinicopathological features and prognosis of patients with PDAC